AcuityMD, an AI platform for MedTech, has launched a new research agent in AcuityAI. The tool brings MedTech market analysis into minutes, helping industry leaders evaluate markets and make informed decisions. It delivers company, brand, and product-level market share data, pricing comparisons, and patient pathway analyses. Additionally, it helps calculate total addressable market (TAM) size.
Historically, market analysis for MedTech takes weeks or even months. Information is collected from claims data, syndicated research, clinical research, and internal research. While general AI accelerates the research process, it does not have all the necessary industry data.
AcuityMD tackles this problem through the unique MedTech ontology. The ontology links together physicians, facilities, networks, procedures, and reimbursement data. Hence, the research tool can perform multiple analysis steps customized for the company’s market. In addition, the research tool will provide citations along the way and enable the users to redo their analysis with new data.
AI Research Agent Supports Strategic MedTech Decisions
The new representative will assist the management of MedTech companies in assessing the competitive positioning, product possibilities, and possible acquisitions. For instance, there is the ability to compare the pricing of competitors and see the change in their market share. Additionally, there is an opportunity for marketing and product teams to explore new indications and patient care paths.
AcuityMD plans to make the research agent available to select users. The tool provides a data-driven foundation for business planning, investment decisions, and mergers and acquisitions.
“AcuityAI brings objective data into our diligence process, proving particularly valuable in our understanding of markets and how they’re evolving over time,” said Chris Murray, Principal at MVM Partners, an investment company with a global outlook spanning medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other sectors of healthcare.
MVM Partners invests across medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other healthcare sectors.
“MedTech teams now have a faster path from a market question to a decision, directly within AcuityAI,” said Brian Collins, AcuityMD Chief Product Officer. “Our research agent brings together deep MedTech context and real-world industry data and activity, not directional estimates from syndicated reports, general-purpose datasets, or vague, forward-looking opinion surveys. Research that used to take weeks or even months can now be completed in minutes.”
He said that the reason is that the technology brings together specialized MedTech knowledge along with actual industry information. Moreover, it does not depend just on directionality or broad general data sets or opinions alone. According to Collins, what took weeks and even months to complete in previous research can now be done in a matter of minutes.
Want more marketing excellence stories? Visit MarTech News for insights, trends, and expert updates.
News Source: Businesswire.com
